Trial Profile
Phase IIb trial of an optimised formulation of auriclosene for impetigo
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Aug 2014
Price :
$35
*
At a glance
- Drugs Auriclosene (Primary)
- Indications Impetigo
- Focus Therapeutic Use
- Sponsors NovaBay Pharmaceuticals
- 10 Jul 2014 NovaBay Pharmaceuticals expects to continue with this phase II study if the results of the new formulation from the study in healthy volunteers is supportive of further development.
- 24 Dec 2013 New trial record